RAIA DROGASIL S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.27 BRL | +2.46% |
|
+2.54% | -10.65% |
| Mar. 06 | Transcript : Raia Drogasil S.A., Q4 2023 Earnings Call, Mar 06, 2024 | |
| Mar. 05 | Raia Drogasil S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Raia Drogasil S.A.
Price target over the last 5 years
History of analyst recommendation changes
ac9fe045fe49d1d9993.UqoBBP77-CjD1RQANjQ6T13ie7C1nJcfZEocLKqH-Hc.ZtpEbdOklk2vmmJVb0F-PT-7AdrA_-dZBnNFa-iqsk8k-U50j7KPUoSjTQ~0a6a35779f2f4537214a53b6baebe1ed
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
25.64
BRL
Average target price
30.93
BRL
Spread / Average Target
+20.63%
High Price Target
36
BRL
Spread / Highest target
+40.41%
Low Price Target
23
BRL
Spread / Lowest Target
-10.30%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B
EPS Revisions
- Stock Market
- Equities
- RADL3 Stock
- Consensus Raia Drogasil S.A.
